Rare genetic variant burden in DPYD predicts severe fluoropyrimidine-related toxicity risk-Reference-Cited by-同舟云学术

Rare genetic variant burden in DPYD predicts severe fluoropyrimidine-related toxicity risk

Published:2022-10 Issue: Volume:154 Page:113644
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

De Mattia Elena,Silvestri Marco,Polesel Jerry,Ecca Fabrizio,Mezzalira Silvia,Scarabel Lucia,Zhou Yitian,Roncato Rossana,Lauschke Volker M.,Calza Stefano,Spina Michele,Puglisi Fabio,Toffoli Giuseppe,Cecchin Erika

Funder

Horizon 2020 Framework Programme

Horizon 2020

Ministero della Salute

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference50 articles.

1. Individualized dosing of fluoropyrimidine-based chemotherapy to prevent severe fluoropyrimidine-related toxicity: what are the options?;Knikman;Clin. Pharm. Ther.,2021

2. Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: ready for prime time;Lunenburg;Eur. J. Cancer,2016

3. Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: assessment of a multiparametric approach;Boisdron-Celle;Semin Oncol.,2017

4. Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: a potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosage;Gamelin;J. Clin. Oncol.,1999

5. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 Update;Amstutz;Clin. Pharm. Ther.,2018

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dihydropyrimidine Dehydrogenase Polymorphism c.2194G>A Screening Is a Useful Tool for Decreasing Gastrointestinal and Hematological Adverse Drug Reaction Risk in Fluoropyrimidine-Treated Patients;Current Issues in Molecular Biology;2024-09-04

2. Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD;Genome Medicine;2024-08-15

3. MIR27A Gene Polymorphism Modifies the Effect of Common DPYD Gene Variants on Severe Toxicity in Patients with Gastrointestinal Tumors Treated with Fluoropyrimidine-Based Anticancer Therapy;International Journal of Molecular Sciences;2024-08-04

4. Approach for Phased Sequence-Based Genotyping of the Critical Pharmacogene Dihydropyrimidine Dehydrogenase (DPYD);International Journal of Molecular Sciences;2024-07-11

5. Transporter-mediated drug-drug interactions: regulatory guidelines, in vitro and in vivo methodologies and translation, special populations, and the blood-brain barrier;Drug Metabolism Reviews;2024-07-05